Preview

Nephrology (Saint-Petersburg)

Advanced search

AGE AND ARTERIAL PRESSURE IN HEMODIALYSIS PATIENTS

https://doi.org/10.24884/1561-6274-2005-9-1-34-38

Abstract

THE AIM of the investigation was to assess the effects of age on the parameters of systemic arterial pressure (AP) in a group of patients treated by hemodialysis (HD). PATIENTS AND METHODS. Under examination there were 252 patients on chronic HD. The average duration of HD was 62±53 months. Primary renal pathology was presented by chronic glomerulonephritis (68%), polycystosis of the kidneys (9%), malformations of the urinary tracts (7%), interstitial diseases (16%). Mean values of the age in the group under examination were 42.9±12.7 years (1974 years, 95% confidence interval 41.444.5 years). RESULTS. A comparative analysis of mean values of systolic (SAP), diastolic (DAP), average (APaver) and pulse AP (PAP) has revealed that AD (PAP excluded) has lower values in the group of elderly patients of 6074 years of age, and the highest values  among the patients of 1944 years of age. The AP values in 4559 year old patients were intermediate (all Panova <0.005). A clear negative dependence was found between the current age of the HD patients and the values of SAP, DAP and APaver(all p<0.001). PAP did not depend on the age (r=0.107, p=0.09). By the data of multiple regressive analysis the age was included in the group of independent and reliable predictors of the APaver level (β=0.269, p=0.0003) along with the duration of the dialysis therapy (β=0.311, p=0.000021), duration of the HD procedure (β=0.241, p=0.0007), the aorta diameter (β=0.176, p=0.0189) and the calciumphosphate product (Ca* P) (β=0.154, p=0.0274). The same analysis used for SAP and DAP gave similar results with the retained high reliability of the final regression model (R2 =0.324, p=0.0001 and R2 =0.313, p=0.0001, respectively). PAP was determined by the duration of HD treatment (β=0.3, p=0.00002), average duration of the HD procedure (β=0.19, p=0.008) and Ca* P (β=0.2, p=0.005). CONCLUSION. The data obtained need additional investigations in order to specify the mechanisms of agedependent change of AP and show a more careful approach to be necessary to its control in patients of the middle and elderly age including pharmacotherapy and choice of the HD regimen.

About the Authors

V. A. Dobronravov
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Омская областная больница
Russian Federation


A. V. Smirnov
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Омская областная больница
Russian Federation


E. V. Babarykina
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Омская областная больница
Russian Federation


E. A. Borovskaya
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Омская областная больница
Russian Federation


Yu. V. Vladimirova
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Омская областная больница
Russian Federation


R. V. Konoshkova
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Омская областная больница
Russian Federation


A. A. Kuznetsov
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Омская областная больница
Russian Federation


References

1. Port FK, HulbertShearon TE, Wolfe RA et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33(3):50717

2. Zager PG, Nikolic J, Brown RH et al. «U» curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998; 54(2): 561569

3. Foley RN, Herzog CA, Collins AJ. Blood pressure and longterm mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int 2002; 62(5):17841790

4. Klassen PS, Lowrie EG, Reddan DN et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 2002; 287(12): 15481555

5. Franklin SS, Gustin W, Wong ND et al. Hemodynamic patterns of agerelated changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96(1): 308315

6. Salem MM. Hypertension in the hemodialysis population: a survey of 649 patients. Am J Kidney Dis 1995; 26(3): 461468

7. Foley RN, Parfrey PS, Harnett JD et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end stage renal disease. Kidney Int 1996; 49(5): 13791385

8. Abdelfatah AB, Motte G, Ducloux D, Chalopin JM. Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients. J Hum Hypertens 2001; 15(11): 775779

9. Kovacic V, Roguljic L, Kovacic V et al. Mean arterial pressure and pulse pressure are associated with different clinical parameters in chronic haemodialysis patients. J Hum Hypertens 2003; 17( 5): 353360

10. Daugirdas JT. Second generation logarithmic estimates of singlepool variable volume KtV: An analysis of error. J Am Soc Nephrol 1993; 4: 12051213

11. Level C., Lasseur C., Delmas Y. et al. Determinants of arterial compliance in patients treated by hemodialysis. Clin Nephrol 2001; 56(6): 435444

12. Dumler F, Kilates C. Body composition analysis by bioelectrical impedance in chronic maintenance dialysis patients: comparisons to the National Health and Nutrition Examination Survey III. J Ren Nutr 2003; 13(2): 166172

13. Kyle UG, Genton L, Hans D et al. Agerelated differences in fatfree mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur J Clin Nutr 2001; 55(8): 663672

14. Kyle UG, Genton L., Slosman D.O. et al. Fatfree and fat mass percentiles in 5225 healthy subjects aged 15 to 98 years. Nutrition 2001; 17(78): 534541

15. Capuano A, Sepe V, Cianfrone P et al. Cardiovascular impairment, dialysis strategy and tolerance in elderly and young patients on maintenance haemodialysis. Nephrol Dial Transplant 1990; 5(12): 10231030

16. Tozawa M, Iseki K, Iseki C et al. Evidence for elevated pulse pressure in patients on chronic hemodialysis: a case control study. Kidney Int 2002; 62(6): 21952201

17. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in endstage renal disease. Nephrol Dial Transplant 2000; 15(7): 10141021


Review

For citations:


Dobronravov V.A., Smirnov A.V., Babarykina E.V., Borovskaya E.A., Vladimirova Yu.V., Konoshkova R.V., Kuznetsov A.A. AGE AND ARTERIAL PRESSURE IN HEMODIALYSIS PATIENTS. Nephrology (Saint-Petersburg). 2005;9(1):34-38. (In Russ.) https://doi.org/10.24884/1561-6274-2005-9-1-34-38

Views: 431


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)